Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer

Background: The application of chimeric antigen receptor (CAR) NK cells in solid tumors is hindered by lack of tumor-specific targets and inefficient CAR NK cell efficacy. It has been reported that mesothelin (MSLN) may be an ideal immunotherapy target for gastric cancer. However, the feasibility of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Bihui, Liu, Manting, Huang, Jingjun, Zhou, Jingwen, Li, Junping, Lian, Hui, Huang, Wensou, Guo, Yongjian, Yang, Shuo, Lin, Liteng, Cai, Mingyue, Zhi, Cheng, Wu, Jingqiang, Liang, Licong, Hu, Yuling, Hu, Hong, He, Jinping, Liang, Baoxia, Zhao, Qi, Zhu, Kangshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495380/
https://www.ncbi.nlm.nih.gov/pubmed/34671203
http://dx.doi.org/10.7150/ijbs.64630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495380/
https://www.ncbi.nlm.nih.gov/pubmed/34671203
http://dx.doi.org/10.7150/ijbs.64630

Ejemplares similares